Access Statistics for Anirban Basu

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Choosing Wisely: Evaluating Latent Factor Models in the Presence of a Contaminated Instrumental Variable with Varying Strength 0 0 1 1 0 6 31 31
Comparing 2SLS vs 2SRI for Binary Outcomes and Binary Exposures 0 0 2 48 12 27 47 128
Do For-Profit Hospitals Cream-Skim Patients? Evidence from Inpatient Psychiatric Care in California 0 0 4 14 3 6 16 30
Dynamic Efficiency and Pricing of Innovations with Insurance: The Case for Gene Therapies 0 0 0 5 1 9 10 24
Economics of Individualization in Comparative Effectiveness Research and a Basis for a Patient-Centered Health Care 0 0 1 48 1 13 21 195
Estimating Lifetime or Episode-of-illness Costs 0 0 1 109 2 7 10 295
Estimating Person-Centered Treatment (PeT) Effects Using Instrumental Variables 0 0 0 52 2 4 5 159
Exploring comparative effect heterogeneity with instrumental variables: prehospital intubation and mortality 0 0 0 39 2 4 12 197
Exploring comparative effect heterogeneity with instrumental variables: prehospital intubation and mortality 0 0 0 18 1 8 11 108
Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data 0 1 1 47 4 9 10 170
Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data 0 0 0 290 0 3 7 879
Hidden Figures: Uncovering Quantities Behind Zeros with Econometrics 0 0 0 16 2 4 5 26
Impact of Rural and Urban Hospital Closures on Inpatient Mortality 0 0 0 86 2 11 16 170
Political Polarization, Anticipated Health Insurance Uptake and Individual Mandate: A view from the Washington State 0 0 0 16 0 2 2 39
Price Elasticities of Pharmaceuticals in a Value-Based-Formulary Setting 0 1 1 63 1 8 16 109
Returns to Pharmaceutical Innovation in the Market for Oral Chemotherapy in Response to Insurance Coverage Expansion 0 0 0 50 1 6 7 41
Service-level Selection: Strategic Risk Selection in Medicare Advantage in Response to Risk Adjustment 0 0 0 7 2 23 25 75
The Impact of Comparative Effectiveness Research on Health and Health Care Spending 0 0 0 57 2 7 8 236
The New Prescription Drug Paradox: Pipeline Pressure and Rising Prices 0 0 0 73 2 3 9 111
The Role of Physician Altruism in the Physician-Industry Relationship 0 1 9 12 0 6 14 24
The Roles of Cognitive and Non-Cognitive Skills in Moderating the Effects of Mixed-Ability Schools on Long-Term Health 0 0 0 42 3 4 5 106
The impact of Medicare Part D on Medicare-Medicaid Dual-eligible Beneficiaries' Prescription Utilization and Expenditures 0 0 0 42 0 6 8 170
Understanding Algorithmic Discrimination in Health Economics Through the Lens of Measurement Errors 0 0 0 21 1 5 9 59
Use of Propensity Scores in Non-Linear Response Models: The Case for Health Care Expenditures 0 0 0 54 1 5 6 224
Use of instrumental variables in the presence of heterogeneity and self-selection: An application in breast cancer patients 0 0 1 484 0 7 13 1,353
Use of propensity scores in non-linear response models: The case for health care expenditures 0 0 1 147 0 5 11 530
Welfare Implications of Learning Through Solicitation versus Diversification in Health Care 0 0 0 36 0 4 7 62
Total Working Papers 0 3 22 1,877 45 202 341 5,551


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
CAN WE MAKE SMART CHOICES BETWEEN OLS AND CONTAMINATED IV METHODS? 0 0 0 3 0 4 5 29
Comparing alternative models: log vs Cox proportional hazard? 0 0 1 148 0 5 8 577
Does Competition under Medicare Prospective Payment Selectively Reduce Expenditures on High-Cost Patients? 0 0 0 0 1 5 11 325
ESTIMATING PERSON‐CENTERED TREATMENT (PeT) EFFECTS USING INSTRUMENTAL VARIABLES: AN APPLICATION TO EVALUATING PROSTATE CANCER TREATMENTS 0 0 0 6 0 2 9 50
Economics of individualization in comparative effectiveness research and a basis for a patient-centered health care 0 0 0 29 1 6 12 256
Erratum: Estimating lifetime or episode‐of‐illness costs under censoring 0 0 0 15 0 3 5 51
Estimating lifetime or episode‐of‐illness costs under censoring 0 1 3 23 3 12 19 98
Extended generalized linear models: Simultaneous estimation of flexible link and variance functions 0 0 1 145 1 4 6 425
Generalized modeling approaches to risk adjustment of skewed outcomes data 0 0 0 143 0 3 4 362
HETEROGENEITY IN ACTION: THE ROLE OF PASSIVE PERSONALIZATION IN COMPARATIVE EFFECTIVENESS RESEARCH 0 0 0 2 1 6 7 31
HIGHLIGHTING DIFFERENCES BETWEEN CONDITIONAL AND UNCONDITIONAL QUANTILE REGRESSION APPROACHES THROUGH AN APPLICATION TO ASSESS MEDICATION ADHERENCE 0 0 1 105 1 8 13 300
Implications of spillover effects within the family for medical cost-effectiveness analysis 0 0 0 72 1 6 15 199
Measuring the Value of Pharmaceuticals in the US Health System 0 0 0 5 1 1 1 15
Person-centered treatment (PeT) effects: Individualized treatment effects using instrumental variables 0 0 2 40 1 2 8 157
Personalized Medicine in the Context of Comparative Effectiveness Research 0 0 0 13 3 7 8 110
Private Manufacturers’ Thresholds to Invest in Comparative Effectiveness Trials 0 0 0 5 1 4 5 52
RESPONSE TO EPSTEIN'S COMMENT ON “HETEROGENEITY IN ACTION” 0 0 0 1 2 4 4 22
Scale of interest versus scale of estimation: comparing alternative estimators for the incremental costs of a comorbidity 0 0 0 52 1 4 4 221
The impact of comparative effectiveness research on health and health care spending 0 0 0 35 2 7 9 283
Two-stage residual inclusion estimation: Addressing endogeneity in health econometric modeling 1 3 11 933 12 34 78 2,777
Welfare implications of learning through solicitation versus diversification in health care 0 0 0 2 1 5 7 41
Total Journal Articles 1 4 19 1,777 33 132 238 6,381


Software Item File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
IVCHECK: Stata module to choose between OLS and contaminated IV 0 0 3 28 2 7 19 252
Total Software Items 0 0 3 28 2 7 19 252


Statistics updated 2026-03-04